Join us as we learn from each other, see old friends, and forge new collaborations while celebrating Dr. Landsberg’s legacy. NU Internal Medicine Anand Patel Northwestern Medicine

Multi-Cancer Early Detection tests are promising-a new era in cancer care!

Many opportunities for collaboration and learning from each other! #NACLC22 starting soon-stellar educational and scientific content! IASLC

Wonderful team effort!

And we’re off! Morning session chaired by donington and Nisha Mohindra Lurie Cancer Center Impact of ICIs in NSCLC-Implications of Cure.#NACLC IASLC

Dr. Marianne Davies Yale Cancer Center presenting on survivorship issues in post ICI curative setting. We have much to learn and there is room for improvement as we increase the number of lung cancer survivors! IASLC #NACLC22

Reducing systemic barriers is essential to improve healthcare for all. We can do this. Danielle Dressler, MD Joe Fuchs Chetan Vakkalagadda, MD NU Internal Medicine Lurie Cancer Center

SCLC updates at #NACLC22. Dr Saiama Waqar reviews second line strategies. Aditya Juloori discusses implications of radiation in improving outcomes-survival and the quality of that survival. Fantastic panel Greg Durm Jill Feldman Dr. Siddharth’s Devarakonda Shruti Patel, MD IASLC

So great to walk in solidarity to improve lung cancer outcomes. Thank you to the patients, families, caregivers, healthcare providers and researchers who come together to affirm our commitment Lurie Cancer Center Northwestern Medicine #lcsm

We’re recognizing and celebrating our Lung Cancer patients Lurie Cancer Center this November. #LungCancerAwarenessMonth #shinealight #whiteribbonproject Respiratory Health Association UChicagoCancerCenter University of Illinois Cancer Center

Excited to share #RWD to examine outcomes to ICI vs ICI+CTx in NSCLC with KRAS, STK11, KEAP1 mutations #SITC2022. This is a heterogenous group & requires a tailored approach. This data has implications not only for treatment selection but also for trial design #LCSM

Excellent and important work. Understanding SCLC’s state diversity, likely a major feature of its clinical versatility and lethality, will help us improve outcomes🙌Congratulations Mohamed Abazeed, MD, PhD !!

Today, on #WorldCancerDay, February 4, let’s come together in our commitment to end cancer. Think about how what you can do to #CloseTheCareGap

Clinical trials remain vitally important in improving cancer outcomes. In fact, all of our best therapies were once studied in a clinical trials. Participants in a trial have potential access to tomorrow’s treatments, more options, and extra oversight. #Lurie #lcsm

#ASCO23 Partnering with Patients and bringing impactful advances to the bedside. #CancerDotNet is a powerful resource for people with cancer, people who know someone with cancer, and all of us who want to decrease the burden of this disease.

#ASCO23 ASCO Presenting on real world outcomes of 1L ICI in KRASG12C MT #NSCLC ➡️ Pts with KRASMT TPS<1 have worse OS! ➡️ Co-mutations w/ STK11/ KEAP assoc with worse OS ⁦OncoAlert⁩ ⁦OOO⁩ ⁦Jyoti D Patel⁩

The best cancer care starts with the best cancer information. Cancer.Net brings the expertise and resources of #ASCO to people living with cancer. The Cancer.Net mobile app helps manage care, get updates, and stay informed.

Submit your groundbreaking research, whether it's a Late-Breaking Abstract (LBA) or a regular abstract, for the IASLC #NACLC23 by 10/8/23. Be a catalyst for advancements in #lungcancer treatment. Learn more & submit your abstract: ow.ly/c51c50PQMP5 #LCSM

New evidence-based updates to 2 guidelines on the treatment of stage IV #NSCLC w/ & w/o driver alterations discuss treatment options, cost considerations, health disparities & more. 👉 brnw.ch/21wHsjd Jyoti D Patel Dwight Owen #LCSM #lungcancer #ASCODailyNews

Lung cancer exacts an enormous toll on women’s health. It’s time to up our efforts to better understand its impact on women. Khyati Somayaji